Scholars Central

OtherPublished 5 Feb 2012

Overview on the efficacy and safety of gadobutrol: an MRI contrast agent for the CNS, body and vessels

Authors: Juan E Gutierrez, Sara Koenig, Josy Breuer

Imaging in Medicine

Volume 4 · Issue 1 · Pages 25–40

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Contrast-enhanced MRI has become a mainstay of clinical imaging with unlimited applications. However, a limitation of conventional contrast agents in MRI is the insufficient signal-to-noise ratios due to relaxivity. Gadobutrol (1.0 mmol/ml), an extracellular macrocyclic contrast agent of high stability, is indicated for contrast-enhanced MRI of adults, adolescents and children 2 years of age and older. Gadobutrol offers increased T1 relaxivity, which improves MR image quality and clinical use of the technique.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Imaging in Medicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalImaging in Medicine
  • SubjectRadiology & Imaging
  • BylineArticles whose byline prints “Juan E Gutierrez”
  • BylineArticles whose byline prints “Sara Koenig”
  • BylineArticles whose byline prints “Josy Breuer”